SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers

Vural Tagal(Southwestern Medical Center), Michael G. Roth(The University of Texas Southwestern Medical Center)
Nature Communications
January 19, 2017
10.1038/ncomms14098
Cited by 115

Related Papers

Dapagliflozin suppresses glucagon signaling in rodent models of diabetes
|Proceedings of the National Academy of Sciences|2017|33
Inhibition of Iron Uptake Is Responsible for Differential Sensitivity to V-ATPase Inhibitors in Several Cancer Cell Lines
|PLoS ONE|2010|26